Reference : European Union diabetes indicators: Fact or fiction?

	Document type :	Scientific journals : Article
	Discipline(s) :	Human health sciences : Multidisciplinary, general & others
	To cite this reference:	http://hdl.handle.net/10993/27208

Title :	European Union diabetes indicators: Fact or fiction?
Language :	English
Author, co-author :	De Beaufort, Carine [University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) >]
	Reunanen, A. [National Public Health Institute, Helsinki, Finland]
	Raleigh, V. [Commission for Health Improvement, London, United Kingdom]
	Storms, F. [MESOS Diabetes Centrum, Bilthoven, Netherlands]
	Kleinebreil, L. [Hopital G Pompidou, Paris, France]
	Gallego, R. [Ministry of Health, Lisbon, Portugal]
	Giorda, C. [Ospedale Maggiore, Chieri, Italy]
	Midthjell, K. [Norwegian Univ. of Sci. and Technol., Verdal, Norway]
	Jecht, M. [GK Havelhohe Med Klinik/Diabetologie, Berlin, Germany]
	De Leeuw, I. [> >]
	Schober, E. [University Children's Hospital, Vienna, Austria]
	Boran, G. [Adelaide and Health Hospital, Dublin, Ireland]
	Tolis, G. [Hippokratis General Hospital, Athens, Greece]
Publication date :	2003
Journal title :	European Journal of Public Health
Volume :	13
Issue/season :	3 SUPPL.
Pages :	51-54
Peer reviewed :	Yes (verified by ORBilu)
ISSN :	11011262
Keywords :	[en] Complications ; Diabetes mellitus ; European Union ; Indicators ; Comorbidity ; Diabetes Complications ; Diabetes Mellitus ; Europe ; Health Status Indicators ; Humans ; Incidence ; International Cooperation ; Pilot Projects ; Population Surveillance ; Prevalence ; Public Health Informatics ; Risk Factors
Abstract :	[en] Diabetes mellitus is one of the major causes of morbidity and mortality in EU/EFTA countries. Monitoring risk factors for diabetes and its complications will offer the possibility to evaluate the development in time as well as the influence of possible interventions. In this investigation a list with core and secondary indicators is proposed. Availability of these indicators and their data sources is discussed. An important variability of data sources is used in EU/EFTA countries, interfering with the comparability of the outcome. Further harmonisation as well as continuous evaluation of data sources will be necessary to provide reliable tools to monitor diabetes mellitus and its outcome on a routine basis.
Permalink :	http://hdl.handle.net/10993/27208

There is no file associated with this reference.

All documents in ORBi^lu are protected by a user license.

 

University of Luxembourg Library |  Feedback |  Legal notices Site Map